Christopher Hwang
Technik-/Wissenschafts-/F&E-Leiter bei TRANSCENTA HOLDING LIMITED
Profil
Christopher Hwang is currently the Chief Technology Officer & Executive VP at Transcenta Holding Ltd.
Prior to this, he worked at Genzyme Corp.
and Sanofi as a Senior Director from 1992 to 2016.
He received his undergraduate degree from Massachusetts Institute of Technology in 1985 and his doctorate degree from the same institution in 1992.
Aktive Positionen von Christopher Hwang
Unternehmen | Position | Beginn |
---|---|---|
TRANSCENTA HOLDING LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2019 |
Ehemalige bekannte Positionen von Christopher Hwang
Unternehmen | Position | Ende |
---|---|---|
SANOFI | Direktor/Vorstandsmitglied | 01.09.2016 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | 01.02.2016 |
Ausbildung von Christopher Hwang
Massachusetts Institute of Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
TRANSCENTA HOLDING LIMITED | Health Technology |
SANOFI | Health Technology |
Private Unternehmen | 1 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |